Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma

Tsu Yi Chao, Kuan Chi Chow, Jang Yang Chang, Chang Chung Wang, Tang Yi Tsao, Horng Jyh Harn, Kwan Hwa Chi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

BACKGROUND. Epstein-Barr virus (EBX) is associated with undifferentiated nasopharyngeal carcinoma (NPC). EBV-encoded nonpolyadenylated RNAs (EBERs) are often used as a marker to detect EBV-infected NPC cells. This study was conducted to document the expression and determine the significance of EBERs in NPC cells at various metastatic sites. METHODS. An in situ hybridization (ISH) technique was used to identify the presence of EBERs in paraffin embedded tissues of primary and metastatic sites obtained from 21 patients with NPC. Nineteen of these patients had undifferentiated lesions, and 2 had squamous cell carcinoma. One hundred and fifty specimens of normal tissues and tissues from patients with a variety of benign and malignant diseases other than NPC served as controls. In the NPC specimens, the expression of latent membrane protein (LMP) and a lytic protein, BZLF-1, were also examined by immunohistochemistry. RESULTS. Tissues from all patients with undifferentiated NPC and one patient with squamous cell carcinoma contained EBERs in the malignant cells; the other case of squamous cell carcinoma was negative. In metastatic NPCs, LMP was expressed in 18% (4 of 22) of tissues whereas BZLF-1 was not expressed in any tissues. EBERs were not detected in the 43 patients with normal tissues and benign lesions. In malignant diseases other than NPC. EBERs were detected in only 2 of 12 cases of non-Hodgkin's lymphoma, 1 of 2 cases of Hodgkin's lymphoma, anti 1 of 6 cases of gastric cancer. CONCLUSIONS. By virtue of the direct correlation between latent EBV infection and NPC, the authors conclude that EBERs can be used as a sensitive marker to identify NPC cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin.

Original languageEnglish
Pages (from-to)24-29
Number of pages6
JournalCancer
Volume78
Issue number1
DOIs
Publication statusPublished - Jul 1 1996
Externally publishedYes

Fingerprint

Human Herpesvirus 4
RNA
Carcinoma
Squamous Cell Carcinoma
In Situ Hybridization
Membrane Proteins
Nasopharyngeal carcinoma
Epstein-Barr Virus Infections
Hodgkin Disease
Paraffin
Non-Hodgkin's Lymphoma
Stomach Neoplasms
Histology
Immunohistochemistry

Keywords

  • BZLF-1
  • EBERs
  • immunohistochemistry
  • In situ hybridization
  • latent membrane protein
  • metastatic lesions
  • undifferentiated NPCs

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. / Chao, Tsu Yi; Chow, Kuan Chi; Chang, Jang Yang; Wang, Chang Chung; Tsao, Tang Yi; Harn, Horng Jyh; Chi, Kwan Hwa.

In: Cancer, Vol. 78, No. 1, 01.07.1996, p. 24-29.

Research output: Contribution to journalArticle

Chao, Tsu Yi ; Chow, Kuan Chi ; Chang, Jang Yang ; Wang, Chang Chung ; Tsao, Tang Yi ; Harn, Horng Jyh ; Chi, Kwan Hwa. / Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. In: Cancer. 1996 ; Vol. 78, No. 1. pp. 24-29.
@article{1194255ea01e44f7bb3d4be2e1f47e8c,
title = "Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma",
abstract = "BACKGROUND. Epstein-Barr virus (EBX) is associated with undifferentiated nasopharyngeal carcinoma (NPC). EBV-encoded nonpolyadenylated RNAs (EBERs) are often used as a marker to detect EBV-infected NPC cells. This study was conducted to document the expression and determine the significance of EBERs in NPC cells at various metastatic sites. METHODS. An in situ hybridization (ISH) technique was used to identify the presence of EBERs in paraffin embedded tissues of primary and metastatic sites obtained from 21 patients with NPC. Nineteen of these patients had undifferentiated lesions, and 2 had squamous cell carcinoma. One hundred and fifty specimens of normal tissues and tissues from patients with a variety of benign and malignant diseases other than NPC served as controls. In the NPC specimens, the expression of latent membrane protein (LMP) and a lytic protein, BZLF-1, were also examined by immunohistochemistry. RESULTS. Tissues from all patients with undifferentiated NPC and one patient with squamous cell carcinoma contained EBERs in the malignant cells; the other case of squamous cell carcinoma was negative. In metastatic NPCs, LMP was expressed in 18{\%} (4 of 22) of tissues whereas BZLF-1 was not expressed in any tissues. EBERs were not detected in the 43 patients with normal tissues and benign lesions. In malignant diseases other than NPC. EBERs were detected in only 2 of 12 cases of non-Hodgkin's lymphoma, 1 of 2 cases of Hodgkin's lymphoma, anti 1 of 6 cases of gastric cancer. CONCLUSIONS. By virtue of the direct correlation between latent EBV infection and NPC, the authors conclude that EBERs can be used as a sensitive marker to identify NPC cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin.",
keywords = "BZLF-1, EBERs, immunohistochemistry, In situ hybridization, latent membrane protein, metastatic lesions, undifferentiated NPCs",
author = "Chao, {Tsu Yi} and Chow, {Kuan Chi} and Chang, {Jang Yang} and Wang, {Chang Chung} and Tsao, {Tang Yi} and Harn, {Horng Jyh} and Chi, {Kwan Hwa}",
year = "1996",
month = "7",
day = "1",
doi = "10.1002/(SICI)1097-0142(19960701)78:1<24::AID-CNCR5>3.0.CO;2-H",
language = "English",
volume = "78",
pages = "24--29",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma

AU - Chao, Tsu Yi

AU - Chow, Kuan Chi

AU - Chang, Jang Yang

AU - Wang, Chang Chung

AU - Tsao, Tang Yi

AU - Harn, Horng Jyh

AU - Chi, Kwan Hwa

PY - 1996/7/1

Y1 - 1996/7/1

N2 - BACKGROUND. Epstein-Barr virus (EBX) is associated with undifferentiated nasopharyngeal carcinoma (NPC). EBV-encoded nonpolyadenylated RNAs (EBERs) are often used as a marker to detect EBV-infected NPC cells. This study was conducted to document the expression and determine the significance of EBERs in NPC cells at various metastatic sites. METHODS. An in situ hybridization (ISH) technique was used to identify the presence of EBERs in paraffin embedded tissues of primary and metastatic sites obtained from 21 patients with NPC. Nineteen of these patients had undifferentiated lesions, and 2 had squamous cell carcinoma. One hundred and fifty specimens of normal tissues and tissues from patients with a variety of benign and malignant diseases other than NPC served as controls. In the NPC specimens, the expression of latent membrane protein (LMP) and a lytic protein, BZLF-1, were also examined by immunohistochemistry. RESULTS. Tissues from all patients with undifferentiated NPC and one patient with squamous cell carcinoma contained EBERs in the malignant cells; the other case of squamous cell carcinoma was negative. In metastatic NPCs, LMP was expressed in 18% (4 of 22) of tissues whereas BZLF-1 was not expressed in any tissues. EBERs were not detected in the 43 patients with normal tissues and benign lesions. In malignant diseases other than NPC. EBERs were detected in only 2 of 12 cases of non-Hodgkin's lymphoma, 1 of 2 cases of Hodgkin's lymphoma, anti 1 of 6 cases of gastric cancer. CONCLUSIONS. By virtue of the direct correlation between latent EBV infection and NPC, the authors conclude that EBERs can be used as a sensitive marker to identify NPC cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin.

AB - BACKGROUND. Epstein-Barr virus (EBX) is associated with undifferentiated nasopharyngeal carcinoma (NPC). EBV-encoded nonpolyadenylated RNAs (EBERs) are often used as a marker to detect EBV-infected NPC cells. This study was conducted to document the expression and determine the significance of EBERs in NPC cells at various metastatic sites. METHODS. An in situ hybridization (ISH) technique was used to identify the presence of EBERs in paraffin embedded tissues of primary and metastatic sites obtained from 21 patients with NPC. Nineteen of these patients had undifferentiated lesions, and 2 had squamous cell carcinoma. One hundred and fifty specimens of normal tissues and tissues from patients with a variety of benign and malignant diseases other than NPC served as controls. In the NPC specimens, the expression of latent membrane protein (LMP) and a lytic protein, BZLF-1, were also examined by immunohistochemistry. RESULTS. Tissues from all patients with undifferentiated NPC and one patient with squamous cell carcinoma contained EBERs in the malignant cells; the other case of squamous cell carcinoma was negative. In metastatic NPCs, LMP was expressed in 18% (4 of 22) of tissues whereas BZLF-1 was not expressed in any tissues. EBERs were not detected in the 43 patients with normal tissues and benign lesions. In malignant diseases other than NPC. EBERs were detected in only 2 of 12 cases of non-Hodgkin's lymphoma, 1 of 2 cases of Hodgkin's lymphoma, anti 1 of 6 cases of gastric cancer. CONCLUSIONS. By virtue of the direct correlation between latent EBV infection and NPC, the authors conclude that EBERs can be used as a sensitive marker to identify NPC cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin.

KW - BZLF-1

KW - EBERs

KW - immunohistochemistry

KW - In situ hybridization

KW - latent membrane protein

KW - metastatic lesions

KW - undifferentiated NPCs

UR - http://www.scopus.com/inward/record.url?scp=0029980163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029980163&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19960701)78:1<24::AID-CNCR5>3.0.CO;2-H

DO - 10.1002/(SICI)1097-0142(19960701)78:1<24::AID-CNCR5>3.0.CO;2-H

M3 - Article

C2 - 8646721

AN - SCOPUS:0029980163

VL - 78

SP - 24

EP - 29

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -